Reimagine Medicine | Novartis United States of America

Media Release
Aug 17, 2005
2005 Release
Media Release
Aug 17, 2004
2004 Release
Media Release
Mar 17, 2023
Novartis Tafinlar + Mekinist approved by FDA for pediatric patients with BRAF V600E low-grade glioma, the most common pediatric brain cancer
Media Release
Apr 12, 2022
Novartis presents new four-year data on efficacy and safety of Kesimpta® (ofatumumab) in people living with relapsing multiple sclerosis
Media Release
Jun 30, 2022
Novartis acquires Kedalion Therapeutics and its innovative ocular delivery platform that could transform patient experience
Media Release
Aug 17, 2004
2004 Release
Media Release
Dec 09, 2007
Photo: New Data Show Gleevec® Halts Progression to Advanced Stages of Life-Threatening Form of Leukemia in Sixth Year of Treatment
Media Release
Aug 17, 2006
News Release 1 Headline
Media Release
Aug 17, 2005
2005 Release
Media Release
Mar 10, 2008
VIDEO: Femara® helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
Media Release
Feb 28, 2008
Everolimus (RAD001) Significantly Extends Progression-Free Survival in Advanced Kidney Cancer Patients After Failure of Other Targeted Therapy
Media Release
Jan 21, 2008
Video and Photo: Tekturna HCT®, a Single-tablet Combination of Tekturna®* and a Diuretic, Receives US Approval for Treatment of High Blood Pressure

‹ Previous page
1
…
26
27
28
29
30
31
32
…
50
› Next page